SCHEMBL3935402

SCHEMBL3935402

Cn1cc(CC(=O)Nc2c[nH]nc2C(=O)O)c2ccccc21.Nc1ccc(F)cc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
MAPT P10636 3/20 0.49
ALDH1A1 P00352 3/20 0.49
LMNA P02545 3/20 0.49
TSHR P16473 1/20 0.48
HTT P42858 1/20 0.48
S1PR2 O95136 1/20 0.47
KDM4E B2RXH2 3/20 0.47
PTPN5 P54829 1/20 0.46
TP53 P04637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
GLS O94925 5/20 0.44
GAA P10253 1/20 0.43
DUSP3 P51452 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2801719 0.91 KDM4E (0.56) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL955030 0.85 MEN1 (0.55) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL4442926 0.76 CDK2 (0.44) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL3940057 0.73 ALDH1A1 (0.46) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL4450271 0.73 HDAC1 (0.53) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL3938054 0.72 ALDH1A1 (0.53) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL3939511 0.70 LMNA (0.48) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL3937668 0.70 ATM (0.55) ALDH1A1LMNAHTTKDM4ERXFP1
SCHEMBL3936265 0.70 KMT2A (0.47) MEN1KMT2AMAPTTSHRTP53
SCHEMBL2930131 0.70 MAPT (0.55) MEN1KMT2AMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049106-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-22 EP disclosed
EP-2046330-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
WO-2008007122-A2 COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed
WO-2008007113-A2 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed